the drop in SP in the last few days ahead of the qrtly is a very bad sign.
I don't expect anything new in the report which in itself is a bad thing.
I'm willing to bet that there's no mention of sales figures of Oraline to Mexico, Russia or China. If that's the case then 2c here we come again.